The New York Times @nytimes
Breaking News: An FDA panel voted against recommending approval of a Pfizer Covid booster for people 16 and older. A second vote for older Americans could follow. The agency is not obliged to follow the committee’s recommendations, but it typically does. https://t.co/hWtiSaHpyC — PolitiTweet.org